Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Market Cap

Vertex Pharmaceuticals has a market cap or net worth of $124.35 billion as of February 21, 2025. Its market cap has increased by 12.51% in one year.

• Market Cap: 124.35B
• Enterprise Value: 114.87B
• 1-Year Change: 12.51%
• Ranking: #109
• Category: Large-Cap
• Stock Price: $484.24

Market Cap Chart

Since December 1, 1998, Vertex Pharmaceuticals's market cap has increased from $611.50M to $124.35B, an increase of 20,234.90%. That is a compound annual growth rate of 22.45%.

Market Cap History

Date	Market Cap	% Change
Feb 20, 2025	123.70B	19.28%
Dec 31, 2024	103.71B	-1.09%
Dec 29, 2023	104.85B	41.44%
Dec 30, 2022	74.13B	32.76%
Dec 31, 2021	55.83B	-9.15%
Dec 31, 2020	61.46B	9.15%
Dec 31, 2019	56.30B	32.95%
Dec 31, 2018	42.35B	11.74%
Dec 29, 2017	37.90B	107.41%
Dec 30, 2016	18.27B	-40.90%
Dec 31, 2015	30.92B	8.21%
Dec 31, 2014	28.57B	64.52%
Dec 31, 2013	17.37B	91.17%
Dec 31, 2012	9.09B	31.16%
Dec 30, 2011	6.93B	-2.69%
Dec 31, 2010	7.12B	-8.32%
Dec 31, 2009	7.76B	69.85%
Dec 31, 2008	4.57B	48.74%
Dec 31, 2007	3.07B	-34.61%
Dec 29, 2006	4.70B	71.34%
Dec 30, 2005	2.74B	223.10%
Dec 31, 2004	848.90M	5.56%
Dec 31, 2003	804.20M	-33.56%
Dec 31, 2002	1.21B	-34.33%
Dec 31, 2001	1.84B	-56.32%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	784.71B
UnitedHealth Group	429.24B
Novo Nordisk	391.83B
Johnson & Johnson	390.76B
AbbVie	356.74B
Abbott Laboratories	234.01B
AstraZeneca	229.50B
Merck & Co.	226.40B